---
category: news
title: "DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development"
excerpt: "MONMOUTH JUNCTION, N.J. and LOS ANGELES, July 5, 2023 /PRNewswire/ -- DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR's microRNA panels and other factors for risk assessment in Alzheimer's disease and Rett syndrome."
publishedDateTime: 2023-07-05T13:30:00Z
originalUrl: "https://it.tmcnet.com/news/2023/07/05/9843362.htm"
webUrl: "https://it.tmcnet.com/news/2023/07/05/9843362.htm"
type: article
quality: 10
heat: -1
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - Machine Learning
  - AI

related:
  - title: "DiamiR Biosciences, JADBio Partner on Machine Learning for Assay Development"
    excerpt: "Under the agreement, DiamiR will use JADBio's Automated Machine Learning Platform to validate its Alzheimer's and Rett syndrome panels."
    publishedDateTime: 2023-07-05T17:33:00Z
    webUrl: "https://www.360dx.com/molecular-diagnostics/diamir-biosciences-jadbio-partner-machine-learning-assay-development"
    type: article
    provider:
      name: 360dx
      domain: 360dx.com
    quality: 18

secured: "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;3MRkHzPcu58KQuFX1mq3Bg=="
---

